Relapse risk of endometrial hyperplasia after treatment with the levonorgestrel-impregnated intrauterine system or oral progestogens.Published in:2016By:Ørbo, A;Arnes, M;Vereide, AB;Straume, B;Ørbo, A;Vereide, A BPublication type:journal article
Levonorgestrel-impregnated intrauterine device as treatment for endometrial hyperplasia: a national multicentre randomised trial.Published in:BJOG: An International Journal of Obstetrics & Gynaecology, 2014, v. 121, n. 4, p. 477, doi. 10.1111/1471-0528.12499By:Ørbo, A;Vereide, AB;Arnes, M;Pettersen, I;Straume, BPublication type:Article